Strategic plan for management of COVID-19 in paediatric haematology and oncology departments
Publication date: Available online 1 April 2020Source: The Lancet HaematologyAuthor(s): Yulei He, Zhi Lin, Daolin Tang, Yang Yang, Tianyou Wang, Minghua Yang (Source: The Lancet Haematology)
Source: The Lancet Haematology - April 2, 2020 Category: Hematology Source Type: research
Transgender health and haematology—a matter of respect
Publication date: Available online 30 March 2020Source: The Lancet HaematologyAuthor(s): Jean M Connors, Saskia Middeldorp (Source: The Lancet Haematology)
Source: The Lancet Haematology - March 31, 2020 Category: Hematology Source Type: research
Intravenous iron: a framework for changing the management of iron deficiency
Publication date: April 2020Source: The Lancet Haematology, Volume 7, Issue 4Author(s): Michael Auerbach, Anat Gafter-Gvili, Iain C Macdougall (Source: The Lancet Haematology)
Source: The Lancet Haematology - March 25, 2020 Category: Hematology Source Type: research
The evolving role of stem cell transplantation
Publication date: April 2020Source: The Lancet Haematology, Volume 7, Issue 4Author(s): The Lancet Haematology (Source: The Lancet Haematology)
Source: The Lancet Haematology - March 25, 2020 Category: Hematology Source Type: research
Paediatric to adult transition care for patients with sickle cell disease: a global perspective
Publication date: April 2020Source: The Lancet Haematology, Volume 7, Issue 4Author(s): Baba Psalm Duniya Inusa, Claire Elizabeth Stewart, Shamarah Mathurin-Charles, Jerlym Porter, Lewis Li-yen Hsu, Wale Atoyebi, Mariane De Montalembert, Ijeoma Diaku-Akinwumi, Norah O Akinola, Biree Andemariam, Miguel Raul Abboud, Marsha Treadwell (Source: The Lancet Haematology)
Source: The Lancet Haematology - March 25, 2020 Category: Hematology Source Type: research
Correction to Lancet Haematol 2019; 6: e551–61
Publication date: April 2020Source: The Lancet Haematology, Volume 7, Issue 4Author(s): (Source: The Lancet Haematology)
Source: The Lancet Haematology - March 25, 2020 Category: Hematology Source Type: research
COVID-19 in a patient with chronic lymphocytic leukaemia
Publication date: April 2020Source: The Lancet Haematology, Volume 7, Issue 4Author(s): Xiang-Hong Jin, Kenneth I Zheng, Ke-Hua Pan, Yu-Peng Xie, Ming-Hua Zheng (Source: The Lancet Haematology)
Source: The Lancet Haematology - March 25, 2020 Category: Hematology Source Type: research
Subcutaneous versus intravenous daratumumab in patients with relapsed or refractory multiple myeloma (COLUMBA): a multicentre, open-label, non-inferiority, randomised, phase 3 trial
Publication date: Available online 23 March 2020Source: The Lancet HaematologyAuthor(s): Maria-Victoria Mateos, Hareth Nahi, Wojciech Legiec, Sebastian Grosicki, Vladimir Vorobyev, Ivan Spicka, Vania Hungria, Sibirina Korenkova, Nizar Bahlis, Max Flogegard, Joan Bladé, Philippe Moreau, Martin Kaiser, Shinsuke Iida, Jacob Laubach, Hila Magen, Michele Cavo, Cyrille Hulin, Darrell White, Valerio De Stefano (Source: The Lancet Haematology)
Source: The Lancet Haematology - March 24, 2020 Category: Hematology Source Type: research
Is there a role for new drugs with alkylating properties in multiple myeloma?
Publication date: Available online 23 March 2020Source: The Lancet HaematologyAuthor(s): María-Victoria Mateos, Verónica González-Calle (Source: The Lancet Haematology)
Source: The Lancet Haematology - March 24, 2020 Category: Hematology Source Type: research
Advancement in monoclonal antibody therapy for multiple myeloma
Publication date: Available online 23 March 2020Source: The Lancet HaematologyAuthor(s): Terri Lynn Shigle, Qaiser Bashir (Source: The Lancet Haematology)
Source: The Lancet Haematology - March 24, 2020 Category: Hematology Source Type: research
Melflufen plus dexamethasone in relapsed and refractory multiple myeloma (O-12-M1): a multicentre, international, open-label, phase 1–2 study
Publication date: Available online 23 March 2020Source: The Lancet HaematologyAuthor(s): Paul G Richardson, Sara Bringhen, Peter Voorhees, Torben Plesner, Ulf-Henrik Mellqvist, Brandi Reeves, Claudia Paba-Prada, Hanan Zubair, Catriona Byrne, Dharminder Chauhan, Kenneth Anderson, Eva Nordström, Johan Harmenberg, Antonio Palumbo, Pieter Sonneveld (Source: The Lancet Haematology)
Source: The Lancet Haematology - March 24, 2020 Category: Hematology Source Type: research
Anti-CD38 monoclonal antibodies in multiple myeloma: another cook in the kitchen?
Publication date: Available online 11 March 2020Source: The Lancet HaematologyAuthor(s): Mattia D'Agostino, Roberto Mina, Francesca Gay (Source: The Lancet Haematology)
Source: The Lancet Haematology - March 12, 2020 Category: Hematology Source Type: research
MOR202, a novel anti-CD38 monoclonal antibody, in patients with relapsed or refractory multiple myeloma: a first-in-human, multicentre, phase 1–2a trial
Publication date: Available online 11 March 2020Source: The Lancet HaematologyAuthor(s): Marc S Raab, Monika Engelhardt, Antje Blank, Hartmut Goldschmidt, Hermine Agis, Igor W Blau, Hermann Einsele, Barbara Ferstl, Natalie Schub, Christoph Röllig, Katja Weisel, Mark Winderlich, Janine Griese, Stefan Härtle, Johannes Weirather, Tiantom Jarutat, Christian Peschel, Manik Chatterjee (Source: The Lancet Haematology)
Source: The Lancet Haematology - March 12, 2020 Category: Hematology Source Type: research
Enasidenib: a magic bullet for myelodysplastic syndromes?
Publication date: Available online 5 March 2020Source: The Lancet HaematologyAuthor(s): Valeria Santini (Source: The Lancet Haematology)
Source: The Lancet Haematology - March 6, 2020 Category: Hematology Source Type: research
Enasidenib in patients with mutant IDH2 myelodysplastic syndromes: a phase 1 subgroup analysis of the multicentre, AG221-C-001 trial
Publication date: Available online 5 March 2020Source: The Lancet HaematologyAuthor(s): Eytan M Stein, Amir T Fathi, Courtney D DiNardo, Daniel A Pollyea, Gail J Roboz, Robert Collins, Mikkael A Sekeres, Richard M Stone, Eyal C Attar, Mark G Frattini, Alessandra Tosolini, Qiang Xu, Wendy L See, Kyle J MacBeth, Stéphane de Botton, Martin S Tallman, Hagop M Kantarjian (Source: The Lancet Haematology)
Source: The Lancet Haematology - March 6, 2020 Category: Hematology Source Type: research
